Leveraging BRG1 Driven Ferroptosis Resistance to Overcome Treatment Resistance
Authors:
- Soo-Yeon HwangSHSoo-Yeon Hwang
- Helgi NikolliHNHelgi Nikolli
- Belem Yoval-SánchezBYBelem Yoval-Sánchez
- Sieun YangSYSieun Yang
- Peter MartinPMPeter Martin
- Caitlin GribbinCGCaitlin Gribbin
- Lalit SehgalLSLalit Sehgal
- Lapo AlinariLALapo Alinari
- Robert A. BaiocchiRBRobert A. Baiocchi
- Inah HwangIHInah Hwang
- Xiangao HuangXHXiangao Huang
- Maurizio DiLibertoMDMaurizio DiLiberto
Preprint
Abstract
Resistance to Bruton’s tyrosine kinase inhibitors (BTKi) remains a major therapeutic challenge in B-cell malignancies, limiting treatment durability. Here, we identify ferroptosis suppression as a central mechanism of BTKi resistance in mantle cell lymphoma (MCL). Aberrant BRG1 activity protects cells from BTKi-induced ferroptosis by restricting reactive oxygen species (ROS) and labile iron. Mechanistically, BRG1 promotes resistance through both BTK-dependent survival signaling and a BTK-independent transcriptional program. The latter is mediated by BRG1-driven induction of MEF2B, which upregulates NDUFA4L2 to inhibit mitochondrial respiration, thereby blocking mitochondria-dependent ferroptosis. Pharmacologic inhibition of BRG1 disrupts these programs, restoring ferroptotic sensitivity and synergizing with BTKi across resistant MCL models. Together, these findings establish BRG1 as a central regulator of therapy resistance and provide a rationale for co-targeting BRG1 and BTK as a therapeutic strategy for B-cell malignancies.Keywords
This publication has 61 references indexed in Scilit:
- CRISPR activation screens identify the SWI/SNF ATPases as suppressors of ferroptosisCell Reports, 2024
- ARID1A orchestrates SWI/SNF-mediated sequential binding of transcription factors with ARID1A loss driving pre-memory B cell fate and lymphomagenesisCancer Cell, 2024
- SMARCA4 is a haploinsufficient B cell lymphoma tumor suppressor that fine-tunes centrocyte cell fate decisionsCancer Cell, 2024
- Parsaclisib, a PI3Kδ inhibitor, in relapsed and refractory mantle cell lymphoma (CITADEL-205): a phase 2 studyeClinicalMedicine, 2023
- BTK inhibition limits B-cell–T-cell interaction through modulation of B-cell metabolism: implications for multiple sclerosis therapyActa Neuropathologica, 2022
- Role of Mitochondria in FerroptosisMolecular Cell, 2019
- Modular Organization and Assembly of SWI/SNF Family Chromatin Remodeling ComplexesCell, 2018
- MEF2B Instructs Germinal Center Development and Acts as an Oncogene in B Cell LymphomagenesisCancer Cell, 2018
- Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic typeThe Journal of Pathology, 2015
- Induction of the Mitochondrial NDUFA4L2 Protein by HIF-1α Decreases Oxygen Consumption by Inhibiting Complex I ActivityCell Metabolism, 2011